North America Fluorescent Immunoassay Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Fluorescent Immunoassay Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Fluorescent Immunoassay Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Fluorescent Immunoassay Market Regional Analysis

6.2 North America Fluorescent Immunoassay Market Revenue 2019-2028 (US$ Million)

6.3 North America Fluorescent Immunoassay Market Forecast Analysis

7. North America Fluorescent Immunoassay Market Analysis – by Product Type

7.1 ELISA

7.1.1 Overview
7.1.2 ELISA: North America Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Rapid Lateral Flow Immunoassay

7.2.1 Overview
7.2.2 Rapid Lateral Flow Immunoassay: North America Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America Fluorescent Immunoassay Market Analysis – by Application

8.1 Infectious Diseases

8.1.1 Overview
8.1.2 Infectious Diseases: North America Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Oncology

8.2.1 Overview
8.2.2 Oncology: North America Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Cardiovascular Diseases

8.3.1 Overview
8.3.2 Cardiovascular Diseases: North America Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America Fluorescent Immunoassay Market Analysis – by End User

9.1 Hospitals & Clinics

9.1.1 Overview
9.1.2 Hospitals & Clinics: North America Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Diagnostic Centers

9.2.1 Overview
9.2.2 Diagnostic Centers: North America Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Pharmaceutical & Biotechnology Companies

9.3.1 Overview
9.3.2 Pharmaceutical & Biotechnology Companies: North America Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.4 Academic & Research Institutes

9.4.1 Overview
9.4.2 Academic & Research Institutes: North America Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. North America Fluorescent Immunoassay Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Fluorescent Immunoassay Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 North America Fluorescent Immunoassay Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America Fluorescent Immunoassay Market Breakdown, by Product Type
10.2.1.1.2 US: North America Fluorescent Immunoassay Market Breakdown, by Application
10.2.1.1.3 US: North America Fluorescent Immunoassay Market Breakdown, by End User

10.2.1.2 Canada: North America Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America Fluorescent Immunoassay Market Breakdown, by Product Type
10.2.1.2.2 Canada: North America Fluorescent Immunoassay Market Breakdown, by Application
10.2.1.2.3 Canada: North America Fluorescent Immunoassay Market Breakdown, by End User

10.2.1.3 Mexico : North America Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America Fluorescent Immunoassay Market Breakdown, by Product Type
10.2.1.3.2 Mexico : North America Fluorescent Immunoassay Market Breakdown, by Application
10.2.1.3.3 Mexico : North America Fluorescent Immunoassay Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 BD

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 bioMerieux SA

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Danaher

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 F. Hoffmann-La Roche Ltd.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Ortho Clinical Diagnostics Holdings plc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Quidel Corporation

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Siemens AG

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Sysmex Corporation

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Thermo Fisher Scientific Inc.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Fluorescent Immunoassay Market